Legal Representation
Attorney
Mary Grieco Lee
USPTO Deadlines
Next Deadline
1778 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241029)
Due Date
October 29, 2030
Grace Period Ends
April 29, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 29, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 29, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 13, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 13, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 24, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 8, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 8, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 8, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 8, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 12, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 28, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 28, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 28, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 26, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 22, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 27, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic
foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and
autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune
diseases; Vaccines; medicated serums for the treatment of cancer and autoimmune diseases; Chemical reagents for medical use;
Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators;
Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the
treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing
Classification
International Classes
005